FASN and colorectal carcinoma: In conclusion, our study establishes that EBV‐miR‐BART18‐3p functions as an oncogenic factor in CRC development by upregulating LDHA‐mediated metabolic processes and the FASN‐mediated de novo lipogenesis pathway.